Ratings Apollo Hospitals Enterprise Limited Bombay S.E.

Equities

APOLLOHOSP

INE437A01024

Market Closed - Bombay S.E. 03:30:55 27/06/2024 pm IST 5-day change 1st Jan Change
6,190 INR +0.85% Intraday chart for Apollo Hospitals Enterprise Limited +0.28% +8.58%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 57% by 2026.
  • The company's profit outlook over the next few years is a strong asset.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • With an expected P/E ratio at 94.59 and 59.72 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company's enterprise value to sales, at 4.82 times its current sales, is high.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+8.58% 1.06TCr -
-33.75% 1.37TCr
B+
+4.15% 1.17TCr
B+
-2.70% 1.15TCr
B
+28.69% 851.77Cr
B
-10.32% 708.53Cr
A-
+7.69% 681.31Cr
B-
+8.41% 648.26Cr
D
0.00% 488.94Cr - -
+14.10% 434.76Cr
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. APOLLOHOSP Stock
  4. APOLLOHOSP Stock
  5. Ratings Apollo Hospitals Enterprise Limited